| 0 (0%) | 12-16 01:27 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 32.59 | 1-year : | 38.06 |
| Resists | First : | 27.9 | Second : | 32.59 |
| Pivot price | 27.62  |
|||
| Supports | First : | 27.16 | Second : | 26.7 |
| MAs | MA(5) : | 27.76 |
MA(20) : | 27.48 |
| MA(100) : | 27.03 |
MA(250) : | 0 | |
| MACD | MACD : | 0.1 |
Signal : | 0 |
| %K %D | K(14,3) : | 92.5 |
D(3) : | 92.2 |
| RSI | RSI(14): 51.7 |
|||
| 52-week | High : | 28.07 | Low : | 22.29 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ FEBU ] has closed below upper band by 48.9%. Bollinger Bands are 16.2% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 27.69 - 27.83 | 27.83 - 27.94 |
| Low: | 27.27 - 27.43 | 27.43 - 27.54 |
| Close: | 27.4 - 27.65 | 27.65 - 27.84 |
Fri, 05 Dec 2025
(FEBU) as a Liquidity Pulse for Institutional Tactics - news.stocktradersdaily.com
Mon, 01 Dec 2025
Félix Guerrero-Ramos, MD, highlights key takeaways from POTOMAC trial - Urology Times
Fri, 28 Nov 2025
Will FEBU stock benefit from mergers - July 2025 Update & Safe Investment Capital Preservation Plans - moha.gov.vn
Fri, 21 Nov 2025
The Best Swedish Dishcloth of 2025 | Reviews by Wirecutter - The New York Times
Sun, 31 Aug 2025
Experts discuss the transformative potential of AI for BPH - Urology Times
Wed, 30 Apr 2025
TAR-200 boasts impressive DFS rates in papillary disease-only NMIBC - Urology Times
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|